Gender and BCR‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia
暂无分享,去创建一个
B. Leber | G. Paré | P. Ainsworth | B. Sadikovic | Hanxin Lin | C. Hillis | J. Sjaarda | J. Dyck | Randa L Stringer | Maria Harvey | R. Carter | Jennifer Sjaarda